Dermapharm Holding SE
DMPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $121 | $159 | $150 | $160 |
| Short-Term Investments | $1 | $1 | $11 | $12 |
| Receivables | $105 | $95 | $100 | $76 |
| Inventory | $340 | $317 | $252 | $241 |
| Other Curr. Assets | $27 | $55 | $22 | $40 |
| Total Curr. Assets | $593 | $630 | $534 | $519 |
| Property Plant & Equip (Net) | $315 | $331 | $226 | $222 |
| Goodwill | $576 | $579 | $271 | $265 |
| Intangibles | $512 | $545 | $305 | $295 |
| Long-Term Investments | $82 | $75 | $65 | $94 |
| Tax Assets | $0 | $0 | $11 | $0 |
| Other NC Assets | $1 | $104 | $0 | $12 |
| Total NC Assets | $1,487 | $1,530 | $879 | $888 |
| Other Assets | $0 | $0 | -$0 | $0 |
| Total Assets | $2,080 | $2,161 | $1,413 | $1,407 |
| Liabilities | – | – | – | – |
| Payables | $95 | $87 | $56 | $52 |
| Short-Term Debt | $90 | $116 | $5 | $6 |
| Tax Payable | $67 | $82 | $111 | $60 |
| Deferred Revenue | $0 | $1 | $155 | $97 |
| Other Curr. Liab. | $75 | $109 | -$109 | -$59 |
| Total Curr. Liab. | $327 | $394 | $218 | $156 |
| LT Debt | $890 | $964 | $512 | $575 |
| Deferred Rev, NC | $11 | $0 | $9 | $9 |
| Deferred Tax Liab, NC | $112 | $0 | $51 | $36 |
| Other NC Liab. | $132 | $268 | $151 | $177 |
| Total NC Liab. | $1,145 | $1,232 | $663 | $752 |
| Other Liabilities | $0 | -$11 | $0 | $0 |
| Cap. Leases | $17 | $18 | $13 | $12 |
| Total Liabilities | $1,472 | $1,616 | $880 | $907 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $54 | $54 | $54 | $54 |
| Retained Earnings | $433 | $367 | $355 | $338 |
| AOCI | $117 | $118 | $122 | $106 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $604 | $539 | $532 | $497 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $4 | $6 | $1 | $3 |
| Total Liab. & Tot. Equity | $2,080 | $2,161 | $1,413 | $1,407 |
| Net Debt | $858 | $922 | $367 | $420 |